Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: A double blind, randomized, placebo-controlled, cross-over trial

Review of Diabetic Studies

Volumn 5, Issue 2, 2008, Pages 102-109

  Parham, Mahmoud ^a   Amini, Massoud ^a   Aminorroaya, Ashraf ^a   Heidarian, Esfandiar ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic nephropathy; Endothelial cell; Microalbuminuria; Oxidative stress; Type 2 diabetes; Zinc

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; LIPID; ORAL ANTIDIABETIC AGENT; PLACEBO; ZINC;

ADD ON THERAPY; ADULT; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DIABETIC PATIENT; DIET RESTRICTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PROTEIN METABOLISM; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; URINARY EXCRETION; ZINC BLOOD LEVEL;

EID: 67649332393     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2008.5.102     Document Type: Article

References (27)

1. Rosen P, Toeller M. Vitamin E in diabetes: increased oxidative stress and its prevention as a strategy to prevent vascular complications. Int J Vitam Nutr Res 1999. 69:206-212. (Pubitemid 29266982)
2. Nakamura T, Ushiyama C, Suzuki S, Shimada N, Ohmuro H, Ebihara I. Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy. Nephron 1999. 83:361-362.
3. Yokoyama H, Kawai K, Kobayashi M. Microalbaminuria is common in Japanese type 2 diabetic patients. Diabetes Care 2007. 30 (4):989-998.
4. Amini M, Safaei H, Aminorroaya A. The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in Isfahan, Iran. Rev Diabet Stud 2007. 4(4):242-248.
5. Kelly FJ. Use of antioxidants in the prevention and treatment of disease. J Int Fed Clin Chem 1998. 10(1):21-23.
6. Baynes JW, Thorpe SR. The role of oxidative stress in diabetic complications. Curropin Endocrinol 1996. 3:277-284. (Pubitemid 126441489)
7. Giugliano D, Cerellio A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996. 19:257-265. (Pubitemid 26070354)
8. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993. 85:687-693. (Pubitemid 23362929)
9. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardio 1996. 27(3):567-574. (Pubitemid 26081917)
10. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006. 20(1):3-18.
11. Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and / or mineral supplementation on glumerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005. 28:2458-2464. (Pubitemid 41384294)
12. Kadhim HM, Ismail SH, Hussein KI, Bakir IH, Sahib AS, Khalaf BH, Hussain SA. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res 2006. 41(2):189-193. (Pubitemid 44141755)
13. Al-Maroof RA, Al-Sharbatti SS. Serum zinc level in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetes. Saudi Med J 2006. 27(3):344-350.
14. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 2003. 22:316-321. (Pubitemid 36927768)
15. O'Brien E, Asmar R, Beilin L. Practice guidelines of the European Society of hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005. 23:697-702. (Pubitemid 40523262)
16. Gosse P. Blood pressure should be measured in both arms on the first consultation. J Hypertens 2002. 20:1045-1055. (Pubitemid 34913611)
17. Stol C. Plasma creatinine determination: a new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965. 17:381-387.
18. Mogensen CE, Keane WF, Bennett PH. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995. 346:1080-1084.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976. 16:31-36.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972. 18:499-502.
21. Arnaud J, Bellanger J, Bienvenu F, Chappuis P, Favier A. Recommended method for assaying serum zinc with flame atomic absorption. Ann Biol Clin 1986. 44:77-87. (Pubitemid 16161839)
22. Hambidge KM, Casey CE, Krebs NF. Zinc. In: Mertz W (editor). Trace elements in human and animal nutrition. 5th ed., Academic Press, New York, 1986, p. 1-10.
23. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993. 36:1051-1056. (Pubitemid 23288775)
24. Song KH, Yoon KH, Kang ML, Cha BY, Lee KW, Son HY, Kang SK. Progression to overt proteinuria in microalbuminuric Koreans with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998. 42(2):117-121. (Pubitemid 28558950)
25. Frohlich ED, Arthus C. Influence of nitric oxide and angiotensin II on renal involvement in hypertension. Hypertension 1997. 29:188-193. (Pubitemid 27074041)
26. Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant 1996. 11:449-456. (Pubitemid 26092783)
27. Bakker S, Gansevoort R, Stuveling EM, Gans R, Zeeuw D. Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? Curr Hypertens Rep 2005. 7:379-384. (Pubitemid 41535778)